Five to fifteen years' maintenance doxepin therapy

Area of Science:

• Psychiatry
• Pharmacology

Background:

• Depression is often viewed as a curable illness, but it can be a chronic condition requiring long-term management.
• Many patients with depression may need extended antidepressant therapy beyond the typical 8-12 month course.
• Chronic depression management is crucial, especially in patients with co-occurring chronic diseases.

Purpose of the Study:

• To review the definition, recognition, and management strategies for chronic depression.
• To evaluate the long-term feasibility, efficacy, and safety of doxepin for chronic depression treatment.

Main Methods:

• Prospective study design.
• Long-term (5-15 years) treatment with doxepin.
• Focus on judicious patient selection and careful monitoring.
• Assessment of drug interactions and safety in patients with comorbidities.

Main Results:

• Doxepin demonstrated feasibility, efficacy, and safety in long-term use.
• No adverse interactions were noted with other prescription or non-prescription drugs.
• High safety profile observed in patients with cardiovascular and other physical disorders.

Conclusions:

• Doxepin is a suitable option for long-term maintenance outpatient treatment of chronic depression.
• Careful patient selection and monitoring are essential for successful long-term doxepin therapy.
• The study supports the use of doxepin in managing chronic depression, particularly in medically complex patients.